"False"
Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Helena Norberg

Helena Norberg

Universitetslektor i farmaci

Programansvarig för farmaciprogrammen

Pedagogisk meritering: Meriterad lärare
0000-0002-6785-2895

Kontakt

E-post
helena.norberg@umu.se
Telefon
090-786 68 21

Verksam vid

Anknytning
Universitetslektor vid Institutionen för medicinsk och translationell biologi Enhet: Grupp Maria Gustafsson
Plats
hus H, Johan Bures väg 12, Biologihuset Umeå universitet, 901 87 Umeå

Jag forskar om optimering av läkemedelsanvändning med fokus på hur nya läkemedel kan implementeras mer systematiskt i vården samt hur AI kan stötta vårdpersonal. Jag är universitetslektor i farmaci och programansvarig för farmaciprogrammen: Receptarieprogrammet, Apotekarprogrammet och Masterprogrammet i farmaci. 

Faricimab versus bevacizumab for neovascular age-related macular degeneration: cost analysis based on real-world data from the Swedish Macula Registry
Acta Ophthalmologica
Abdalla, Souad; Westborg, Inger; Pulkki-Brännström, Anni-Maria; et al.
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin
European Journal of Clinical Pharmacology, Springer Nature 2024, Vol. 80, (9) : 1363-1371
Norberg, Helena; Andersson, Therese; Håkansson, Erik; et al.
Self-reported medication adherence among older people admitted to hospital: a descriptive study
Drugs - real world outcomes, Springer Nature 2023, Vol. 10 : 23-29
Irshaidat, Shayma; Gustafsson, Maria; Norberg, Helena
Older individuals’ experiences of medication management and care after discharge from hospital: an interview study
Patient Preference and Adherence, Dove Medical Press Ltd 2023, Vol. 17 : 781-792
Norberg, Helena; Lindqvist, Marcia Håkansson; Gustafsson, Maria
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study
Open heart, BMJ Publishing Group Ltd 2022, Vol. 9, (2)
Håkansson, Erik; Brunström, Mattias; Norberg, Helena; et al.
Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
BMJ Open, BMJ Publishing Group Ltd 2022, Vol. 12, (9)
Jern, Iréne; Forsell, Sara; Norberg, Helena
Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population
Open heart, BMJ Publishing Group Ltd 2022, Vol. 9, (2)
Jonsson, Anna; Wessberg, Gustav; Norberg, Helena; et al.
Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
European Journal of Clinical Pharmacology, Springer Science+Business Media B.V. 2022, Vol. 78 : 869-877
Norberg, Helena; Sjölander, Maria; Glader, Eva-Lotta; et al.
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
Cardiovascular Therapeutics, Hindawi Publishing Corporation 2021, Vol. 2021
Håkansson, Erik; Norberg, Helena; Själander, Sara; et al.
Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function
PLOS ONE, Public Library of Science 2021, Vol. 16, (10)
Jonsson, Anna; Norberg, Helena; Valham, Fredrik; et al.
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study
European Journal of Clinical Pharmacology, Springer 2021, Vol. 77 : 125-131
Norberg, Helena; Bergdahl, Ellinor; Hellström Ängerud, Karin; et al.
Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure
ESC Heart Failure, John Wiley & Sons 2020, Vol. 7, (3) : 1150-1160
Jonsson, Anna; Viklund, Ida; Jonsson, Andreas; et al.
Bridging the gap between clinical trials and clinical practice: sacubitril-valsartan in heart failure as a model
Umeå University medical dissertations, 2096
Norberg, Helena
Ny metod för regional implementering av nya behandlingar vid kronisk sjukdom
Läkartidningen, Läkartidningen Förlag 2020, Vol. 117, (46-47) : 1518-1518
Norberg, Helena
Differences in medical treatment and clinical characteristics between men and women with heart failure: a single-centre multivariable analysis
European Journal of Clinical Pharmacology, Springer 2020, Vol. 76, (4) : 539-546
Norberg, Helena; Pranic, Veronica; Bergdahl, Ellinor; et al.
Clinical trial enrolment favours men: Fewer women meet eligibility criteria for trials of heart failure medication is discussed by Helena Norberg from Sweden
European Heart Journal, OXFORD UNIV PRESS 2019, Vol. 40, (14) : 1104-1105
Norberg, Helena
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
Cardiovascular Therapeutics, Vol. 2019
Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population
Cardiovascular therapeutics, John Wiley & Sons 2018, Vol. 36, (5)
Jonsson, Anna; Norberg, Helena; Bergdahl, Ellinor; et al.
Who enrols and graduates from web-based pharmacy education: experiences from Northern Sweden
Currents in pharmacy teaching and learning, Elsevier 2018, Vol. 10, (8) : 1004-1012
Mattsson, Sofia; Gustafsson, Maria; Svahn, Sofia; et al.
Eligibility of sacubitril–valsartan in a real-world heart failure population: a community-based single-centre study
ESC Heart Failure, John Wiley & Sons 2018, Vol. 5, (2) : 337-343
Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister
Motives, predictors, and outcomes of MRA discontinuation in a real-world heart failure population
Jonsson, Anna; Wessberg, Gustav; Norberg, Helena; et al.
Visa publikationer i DiVA

Jag undervisar främst inom individanpassning av läkemedelsbehandling inom ämnena farmakoterapi och klinisk farmaci. Jag är kursansvarig för kurserna Läkemedelsbehandling hos äldre 7,5 hp samt Vetenskapliga metoder för värdering av läkemedel 10,5 hp på receptarie- och apotekarprogrammen.